NUCLEOLIN and cancer: Ncl has been a subject of significant interest as a therapeutic target for a diverse range of cancers, owing to its often strong upregulation of expression combined with its various proposed pro‐malignancy functions (Abdelmohsen & Gorospe, 2012).